Literature DB >> 19542903

A critical role for the IL-1 receptor in lung injury induced in neonatal rats by 60% O2.

Ben-Hur Johnson1, Man Yi, Azhar Masood, Rosetta Belcastro, Jun Li, Samuel Shek, Crystal Kantores, Robert P Jankov, A Keith Tanswell.   

Abstract

IL-1 beta, a proinflammatory cytokine, may contribute to the development of the chronic neonatal lung injury, bronchopulmonary dysplasia. Chronic neonatal lung injury was induced in rats, by exposure to 60% O2 for 14 d from birth, to determine whether pulmonary IL-1 expression was up-regulated and, if so, whether a daily s.c. IL-1 receptor antagonist injections would be protective. Exposure to 60% O2 for 14 d caused pulmonary neutrophil and macrophage influx, increased tissue fraction and tyrosine nitration, reduced VEGF-A and angiopoietin-1 expression, and reduced small vessel (20-65 microm) and alveolar numbers. Lung IL-1 alpha and -1 beta contents were increased after a 4-d exposure to 60% O2. IL-1 receptor antagonist treatment attenuated the 60% O2-dependent neutrophil influx, the increased tissue fraction, and the reduced alveolar number. Treatment did not restore VEGF-A or angiopoietin-1 expression and only partially attenuated the reduced vessel number in 60% O2-exposed pups. It also caused a paradoxical increase in macrophage influx and a reduction in small vessels in air-exposed pups. We conclude that antagonism of IL-1-mediated effects can, in major part, protect against lung injury in a rat model of 60% O2-induced chronic neonatal lung injury.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19542903     DOI: 10.1203/PDR.0b013e3181b1bcd2

Source DB:  PubMed          Journal:  Pediatr Res        ISSN: 0031-3998            Impact factor:   3.756


  12 in total

Review 1.  Modulators of inflammation in Bronchopulmonary Dysplasia.

Authors:  Rashmin C Savani
Journal:  Semin Perinatol       Date:  2018-10-02       Impact factor: 3.300

Review 2.  Targeting inflammation to prevent bronchopulmonary dysplasia: can new insights be translated into therapies?

Authors:  Clyde J Wright; Haresh Kirpalani
Journal:  Pediatrics       Date:  2011-06-06       Impact factor: 7.124

3.  Patterns of blood protein concentrations of ELGANs classified by three patterns of respiratory disease in the first 2 postnatal weeks.

Authors:  Matthew Laughon; Carl Bose; Elizabeth N Allred; T Michael O'shea; Richard A Ehrenkranz; Linda J VAN Marter; Alan Leviton
Journal:  Pediatr Res       Date:  2011-09       Impact factor: 3.756

4.  NF-kappaB activation limits airway branching through inhibition of Sp1-mediated fibroblast growth factor-10 expression.

Authors:  John T Benjamin; Billy J Carver; Erin J Plosa; Yasutoshi Yamamoto; J Davin Miller; Jin-Hua Liu; Riet van der Meer; Timothy S Blackwell; Lawrence S Prince
Journal:  J Immunol       Date:  2010-09-22       Impact factor: 5.422

5.  Intermittent hypoxia during recovery from neonatal hyperoxic lung injury causes long-term impairment of alveolar development: A new rat model of BPD.

Authors:  Anastasiya Mankouski; Crystal Kantores; Mathew J Wong; Julijana Ivanovska; Amish Jain; Eric J Benner; Stanley N Mason; A Keith Tanswell; Richard L Auten; Robert P Jankov
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2016-12-02       Impact factor: 5.464

6.  Endothelial Monocyte-Activating Polypeptide II Mediates Macrophage Migration in the Development of Hyperoxia-Induced Lung Disease of Prematurity.

Authors:  Daniel D Lee; Charitharth V Lal; Elizabeth A Persad; Chinn-Woan Lowe; Anna M Schwarz; Niranjan Awasthi; Roderich E Schwarz; Margaret A Schwarz
Journal:  Am J Respir Cell Mol Biol       Date:  2016-10       Impact factor: 6.914

7.  A hyperoxic lung injury model in premature rabbits: the influence of different gestational ages and oxygen concentrations.

Authors:  Roberta Munhoz Manzano; Renata Suman Mascaretti; Valéria Carrer; Luciana Branco Haddad; Aline Rabelo Fernandes; Ana M A Reyes; Celso Moura Rebello
Journal:  PLoS One       Date:  2014-04-22       Impact factor: 3.240

8.  Inhibition of IκBβ/NFκB signaling prevents LPS-induced IL1β expression without increasing apoptosis in the developing mouse lung.

Authors:  Sarah McKenna; Brittany Butler; Laurie Jatana; Sankar Ghosh; Clyde J Wright
Journal:  Pediatr Res       Date:  2017-08-23       Impact factor: 3.756

Review 9.  Animal Models, Learning Lessons to Prevent and Treat Neonatal Chronic Lung Disease.

Authors:  Alan H Jobe
Journal:  Front Med (Lausanne)       Date:  2015-08-07

10.  Refining anti-inflammatory therapy strategies for bronchopulmonary dysplasia.

Authors:  Ina Rudloff; Steven X Cho; Christine B Bui; Catriona McLean; Alex Veldman; Philip J Berger; Marcel F Nold; Claudia A Nold-Petry
Journal:  J Cell Mol Med       Date:  2016-12-13       Impact factor: 5.310

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.